(Q36193437)

12 August 2017

1 reference

title

Meningococcal conjugate vaccine in adolescents and children (English)

1 reference

12 August 2017

Michael E Pichichero

1

1 reference

12 August 2017

language of work or name

1 reference

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

44

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

479-489

1 reference

Bacterial meningitis in the United States in 1995. Active Surveillance Team

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Efficacy of meningococcal vaccine and barriers to vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Risk of meningococcal infection in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Impact of meningococcal C conjugate vaccine in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992280504400603

10.1177/000992280504400603

21 January 2018

Identifiers

DOI

0 references

1 reference